SoracteLite: Innovative Treatment for Benign Prostatic Hyperplasia
SoracteLite is a cutting-edge, micro-invasive treatment for Benign Prostatic Hyperplasia (BPH), offering an alternative to traditional surgery and other minimally invasive techniques that use a transurethral approach. This non-surgical procedure provides relief from BPH symptoms while minimizing the impact on a patient's quality of life.
How SoracteLite Works
SoracteLite utilizes low-power laser energy, typically 3 Watts, applied for a few minutes. The procedure involves:
1. Percutaneous insertion of optical fibers via transperineal access
2. One or two fibers per lobe, depending on the initial volume of the prostatic gland
3. Laser radiation transmitted through extremely thin needles
4. Thermal treatment of the targeted tissue
5. Natural reabsorption of the treated tissue by the gland over subsequent weeks
This process results in a reduction of prostate volume and resolution of BPH symptoms.
Unique Advantages of SoracteLite
1. Transperineal Approach: SoracteLite is the only treatment using a transperineal approach, avoiding traumatic interactions with the urethra and bladder.
2. Minimally Invasive: Uses very thin needles to reach the treatment area, reducing complications associated with transurethral approaches.
3. Short Treatment Duration: The procedure is quick and uses a low dose of energy.
4. Tissue Preservation: No prostate tissue removal, eliminating the risk of bleeding.
5. Non-Surgical: Reduces the risk of sexual complications.
6. Anesthesia-Free: No need for general or loco-regional (spinal) anesthesia.
7. Urethral Protection: No complications to the urethra.
8. Reduced Hospital Stay: Typically performed as a day hospital procedure.
Benefits for Patients
- Improved Quality of Life: Effectively treats BPH symptoms without major surgery.
- Quick Recovery: Minimal downtime due to the non-invasive nature of the procedure.
- Preserved Sexual Function: Lower risk of sexual side effects compared to traditional surgeries.
- Reduced Complications: Minimizes risks associated with transurethral approaches and general anesthesia.
- Customizable Treatment: The number of fibers used can be adjusted based on prostate size.
Ideal Candidates
SoracteLite may be suitable for men who:
- Have been diagnosed with BPH
- Experience moderate to severe urinary symptoms
- Prefer a non-surgical approach
- Wish to avoid potential complications of transurethral procedures
- Are looking for a treatment with minimal impact on sexual function
Conclusion
SoracteLite represents a significant advancement in BPH treatment, offering a safe, effective, and minimally invasive option for men seeking relief from BPH symptoms. By utilizing a unique transperineal approach and low-power laser technology, SoracteLite provides a promising alternative to traditional surgical interventions, potentially improving outcomes and quality of life for BPH patients.
